Skip to main content
OpenTrials
Completed

NCT Number: NCT01749631

Investigation of the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients

The purpose of this study was to record the effectiveness of sevoflurane for intubation in Egyptian, non-obstetric, difficult to intubate (DTI) patients undergoing surgery in regards to the rate of intubation success.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intubation; Difficult

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This is a prospective, open-label, multicenter, post marketing, observational study to investigate the effectiveness of sevoflurane anaesthesia in difficult to intubate (DTI; Mallampati Score III or IV) Egyptian patients who had been prescribed sevoflurane for anaesthesia by their treating physician.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or non-pregnant female over 18 years who are undergoing surgery and using sevoflurane as the anesthetic agent and with Mallampati score III or IV
  • Patients with at least one of the below criteria:
  • Anatomic
  • micrognathia - small mandible
  • macroglossia - large tongue
  • short or fixed neck
  • anterior vocal cords
  • Trauma - neck or face
  • Burns - airway edema
  • Infections - edema
  • Retropharyngeal abscess
  • Submandibular abscess
  • epiglottitis
  • laryngotracheobronchitis (croup)
  • Neoplasms; e.g., laryngeal tumors
  • Rheumatoid arthritis - temporomandibular joint (TMJ) immobility
  • Diabetes mellitus
  • Waxy skin - palm test
  • Decreased functional residual capacity (FRC) - rapid desaturation (due to displaced diaphragm, increased closing capacity and small airway closure, increased oxygen consumption)
  • airway closure in supine position
  • Morbid obesity (body mass index [BMI] >35)
  • Airway edema
  • Laryngospasm
  • Edentulous patients - indent cheeks.
  • Patients willing to sign informed consent

Exclusion criteria

  • Patients with present use of opioids and/or narcotic dependent.
  • Patients with known sensitivity to sevoflurane or to other halogenated agents.
  • Patients with known or suspected genetic susceptibility to malignant hyperthermia.
  • Alcohol addictive patients.
  • Patients with Renal insufficiency (baseline serum creatinine greater than 1.5 mg/dL)
  • Patient is a pregnant or breastfeeding female

Treatment and study plan

Primary outcomes

  1. Percentage of Participants With Successful Intubation (Clinical Success)

    Time frame: Start of intubation to completion of intubation (up to 15 minutes)

    Participants were considered to have a successful intubation if intubation was achieved in less than 4 separate intubation attempts according to the guidelines of the American Society of Anesthesiologists (ASA). The number of intubation attempts was a maximum of 3 attempts, after which the intubation was considered a failure.

Secondary outcomes

  1. Mean Duration of Induction (in Seconds)

    Time frame: From start of induction up to 15 minutes

    The mean duration of induction (in seconds) was defined as the time required to reach a Ramsay Sedation Score (RSS) of 5 from start of induction. The RSS levels are defined as 1 = anxious, agitated or restless; 2 = calm, co-operative and communicative; 3 = response is quick to a voice command; 4 = response is slow to a voice command; 5 = slow or sluggish response; and 6 = no response at all.

  2. Percentage of Participants With Mallampati Score III and IV

    Time frame: Screening

    Mallampati classification correlates tongue size to pharyngeal size. The test is performed with the patient in the sitting position, head in a neutral position, the mouth wide open and the tongue protruding to its maximum, without phonation. Classification is assigned according to the extent the base of tongue is able to mask the visibility of pharyngeal structures: Class I = visualization of the soft palate, fauces; uvula, anterior and the posterior pillars; Class II = visualization of the soft palate, fauces and uvula; Class III = visualization of soft palate and base of uvula; and Class IV: only hard palate is visible, soft palate is not visible at all. A high score (Class III or IV) is associated with more difficult intubation.

  3. Mean Duration of Intubation Procedure (in Minutes)

    Time frame: Start of intubation to completion of intubation (up to 15 minutes)

    The mean duration of intubation procedure (in minutes) was defined as the time from intubation start to the completion of the intubation process (from tube introduction to partial pressure of end-tidal carbon dioxide [PETCO2]).

  4. Percentage of Participants Who Experienced Complications Resulting From Intubation Procedure

    Time frame: Start of intubation to completion of intubation (up to 15 minutes)

    The percentage of participants who experienced complications resulting from the intubation procedure including, but not limited to, bleeding, salivating, and lung aspiration.

  5. Percentage of Participants Who Experienced Difficulties Related to the Use of Sevoflurane

    Time frame: From start of induction to completion of intubation (up to 30 minutes)

    The percentage of participants who experienced difficulties related to the use of sevoflurane including, but not limited to, vocal cords adduction, coughing, movements, and apnea episodes.

  6. Mean Number of Intubation Attempts

    Time frame: Start of intubation to completion of intubation (up to 15 minutes)

Sponsors and collaborators

Lead sponsor

AbbVie (prior sponsor, Abbott)

Industry

Registry information

Official study title

A Prospective, Open-label, Multicenter, Post Marketing, Observational Study to Investigate the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Dec 17, 2012
Registry last updated
Mar 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.